About Mallax Pharma
Sustainability, medical need, and profitable growth are cornerstones of Mallax’s strategy, and they will define how we operate and build our company. Our aim is to build a new leading pharma and healthcare company in Europe.
In 2021, Mallax acquired Sana Pharma Medical AS, a Nordic pharma company headquartered in Oslo. Mallax is the holding company, and all operational activities are carried out through Sana Pharma Medical.